The CDC recently issued a warning regarding Pfizer’s COVID-19 pills—the ones that were approved last year and sold under the name Paxlovid.
People usually take those pills after they contract COVID-19 to lessen the symptoms and lower the chance of hospitalization.
However, a new advisory from the CDC warns Americans that taking Paxlovid can actually lead to a rebound in COVID-19 symptoms—which is a problem that, according to new documentation from the FDA, they were aware of even during the clinical trial phase. Stay tuned for our newsletter so you won’t miss out on our exclusive videos and private events….